Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial
Research output: Contribution to journal › Journal article › Research › peer-review
To evaluate the efficacy of combining the dual endothelin receptor antagonist, bosentan, and the phosfodiesterase-5-inhibitor, sildenafil, in patients with Eisenmenger syndrome.
| Original language | English |
|---|---|
| Journal | European Heart Journal |
| Volume | 31 |
| Issue number | 9 |
| Pages (from-to) | 1124-31 |
| Number of pages | 8 |
| ISSN | 0195-668X |
| DOIs | |
| Publication status | Published - 1 May 2010 |
ID: 34080333